Evidence map›Paper›PMID 42046760›Full record

ArticleProceedings of SPIE--the International Society for Optical Engineering2026

Prostate Cancer Classification Using Quantum Machine Learning on Multi-parametric MRI.

Peng Chen, Mojtaba Safari, Rowan Barker-Clarke, Xiaofeng Yang, Jacob G Scott

Abstract read
In one paragraph

Article in Proceedings of SPIE--the International Society for Optical Engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Peng ChenGenomic Sciences and Systems Biology, Cleveland Clinic Research, Cleveland, OH 44106, USA.
Mojtaba SafariDepartment of Radiation Oncology, Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA.
Rowan Barker-ClarkeGenomic Sciences and Systems Biology, Cleveland Clinic Research, Cleveland, OH 44106, USA.
Xiaofeng YangDepartment of Radiation Oncology, Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA.
Jacob G ScottGenomic Sciences and Systems Biology, Cleveland Clinic Research, Cleveland, OH 44106, USA.

Funding

Translational and Clinical Trial Correlates CoreU54CA274513 · NCI · CLEVELAND CLINIC LERNER COM-CWRU · PI Jacob Gardinier Scott · 2022 to 2026
$9.3M
NCI NIH HHS U54 CA274513
6 · The paper itself

Abstract

Prostate cancer is one of the most common malignancies in men, and accurate classification of lesions into clinically significant or insignificant categories is essential for patient management. Multiparametric MRI, including T2-weighted (T2W) and apparent diffusion coefficient (ADC) imaging, enables extraction of quantitative radiomic features that can be exploited by machine learning for improved diagnosis. While classical machine-learning models such as support vector machines (SVM), random forests (RF), and extreme gradient boosting (XGBoost) have shown strong performance in radiomics-based classification, quantum machine learning offers a new paradigm that leverages quantum feature spaces, potentially uncovering complex patterns inaccessible to classical kernels. In this study, we systematically compared three classical classifiers (SVM-RBF, RF, and XGBoost) with three quantum support vector machine (QSVM) variants: amplitude encoding, angle encoding, and angle encoding with a projected quantum kernel, for classifying 299 prostate lesions from the PROSTATEx Challenge dataset. Radiomics features were extracted from T2W and ADC images. A nested stratified cross-validation pipeline was employed, with feature selection performed in each outer fold and hyperparameters optimized via grid search. QSVM-amplitude encoding achieved the highest mean AUC (0.799 ± 0.082), outperforming SVM-RBF (0.608 ± 0.244) and matching or exceeding RF (0.728 ± 0.083) and XGBoost (0.720 ± 0.065), while offering higher sensitivity at comparable specificity. These findings demonstrate that qubit-efficient QSVMs can deliver competitive or superior performance in small-sample, low-dimensional clinical imaging settings, highlighting their potential for prostate cancer lesion classification.

Indexed as

Multiparametric MRIProstate CancerQuantum machine learningRadiomics

Identifiers

PMID42046760
PMCPMC13110830

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.